Ceribell, Inc.CBLLEarnings & Financial Report
Nasdaq · Health Care · Electromedical & Electrotherapeutic Apparatus
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| FMR LLC | 13.35% | 4.5M | — | 2024-11-07 |
| Longitude Capital Partners IV, LLC | 7.00% | 2.5M | — | 2024-10-22 |
Insider Transactions
Net 90d: −$3.54M · buys $55.2K / sells $3.59MRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-06 | Xingjuan Chao | President and CEO | Sell (open market) | 14.0K | $18.40 | $257.6K |
| 2026-04-06 | Xingjuan Chao | President and CEO | Option exercise | 1.4K | $4.70 | $6.8K |
| 2026-04-06 | Xingjuan Chao | President and CEO | Sell (open market) | 1.4K | $18.40 | $26.6K |
| 2026-04-06 | Xingjuan Chao | President and CEO | Option exercise | 23.6K | $4.70 | $110.7K |
| 2026-04-06 | Xingjuan Chao | President and CEO | Sell (open market) | 23.6K | $18.40 | $433.4K |
| 2026-04-01 | Xingjuan Chao | President and CEO | Grant | 97.6K | $0.00 | $0 |
| 2026-04-01 | Manni Joseph S. | Chief Revenue Officer | Grant | 30.7K | $0.00 | $0 |
| 2026-04-01 | Raymond Woo | Chief Technology Officer | Option exercise | 1.5K | $2.24 | $3.3K |
| 2026-04-01 | Raymond Woo | Chief Technology Officer | Sell (open market) | 1.5K | $18.58 | $27.3K |
| 2026-04-01 | Raymond Woo | Chief Technology Officer | Option exercise | 3.0K | $4.70 | $14.2K |
1–10 of 58
Page 1 / 6